🐜
|
Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice
14 auth.
K. Berer,
L. Gerdes,
Egle Cekanaviciute,
Xiaoming Jia,
L. Xiao,
Z. Xia,
Chuan Liu,
L. Klotz,
U. Stauffer,
S. Baranzini,
...
T. Kümpfel,
R. Hohlfeld,
G. Krishnamoorthy,
H. Wekerle
|
9 |
2017 |
9 🐜
|
🐜
|
Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab
11 auth.
H. Pellkofer,
M. Krumbholz,
A. Berthele,
B. Hemmer,
L. Gerdes,
J. Havla,
...
R. Bittner,
M. Canis,
E. Meinl,
R. Hohlfeld,
T. Kuempfel
|
8 |
2011 |
8 🐜
|
🐜
|
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
13 auth.
M. Spadaro,
L. Gerdes,
M. Krumbholz,
B. Ertl-Wagner,
F. Thaler,
E. Schuh,
I. Metz,
A. Blaschek,
A. Dick,
W. Brück,
...
R. Hohlfeld,
E. Meinl,
T. Kümpfel
|
7 |
2016 |
7 🐜
|
🐜
|
Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
14 auth.
M. Spadaro,
L. Gerdes,
M. C. Mayer,
B. Ertl-Wagner,
S. Laurent,
M. Krumbholz,
C. Breithaupt,
T. Högen,
A. Straube,
A. Giese,
...
R. Hohlfeld,
H. Lassmann,
E. Meinl,
T. Kümpfel
|
7 |
2015 |
7 🐜
|
🐜
|
Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course
43 auth.
Xiaoping Zhou,
Ryan Baumann,
Xiaohui Gao,
Myra Mendoza,
Sneha Singh,
I. K. Sand,
Zongqi Xia,
Laura M. Cox,
T. Chitnis,
H. Yoon,
L. Moles,
S. Caillier,
A. Santaniello,
Gail L Ackermann,
A. Harroud,
...
R. Lincoln,
R. Gomez,
Antonio González Peña,
Elise Digga,
Daniel Hakim,
Y. Vázquez-Baeza,
Karthik Soman,
Shannon Warto,
G. Humphrey,
M. Farez,
L. Gerdes,
J. Oksenberg,
S. Zamvil,
S. Chandran,
P. Connick,
D. Otaegui,
T. Castillo-Triviño,
S. Hauser,
J. Gelfand,
H. Weiner,
R. Hohlfeld,
H. Wekerle,
J. Graves,
A. Bar-Or,
B. Cree,
J. Correale,
R. Knight,
S. Baranzini
|
7 |
2022 |
7 🐜
|
🐜
|
Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein
23 auth.
M. Spadaro,
S. Winklmeier,
E. Beltrán,
C. Macrini,
R. Höftberger,
E. Schuh,
F. Thaler,
L. Gerdes,
S. Laurent,
R. Gerhards,
...
S. Brändle,
K. Dornmair,
C. Breithaupt,
M. Krumbholz,
M. Moser,
G. Krishnamoorthy,
F. Kamp,
D. Jenne,
R. Hohlfeld,
T. Kümpfel,
H. Lassmann,
N. Kawakami,
E. Meinl
|
7 |
2018 |
7 🐜
|
🐬
|
Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment.
J. Havla,
H. Pellkofer,
I. Meinl,
L. Gerdes,
R. Hohlfeld,
T. Kümpfel
|
6 |
2012 |
6 🐬
|
🦁
|
CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis
12 auth.
L. Gerdes,
K. Held,
E. Beltrán,
C. Berking,
J. Prinz,
A. Junker,
...
J. Tietze,
B. Ertl-Wagner,
A. Straube,
T. Kümpfel,
K. Dornmair,
R. Hohlfeld
|
6 |
2016 |
6 🦁
|
🐜
|
Early adaptive immune activation detected in monozygotic twins with prodromal multiple sclerosis.
11 auth.
E. Beltrán,
L. Gerdes,
J. Hansen,
Andrea Flierl-Hecht,
S. Krebs,
H. Blum,
...
B. Ertl-Wagner,
F. Barkhof,
T. Kümpfel,
R. Hohlfeld,
K. Dornmair
|
6 |
2019 |
6 🐜
|
🐜
|
De-escalation from natalizumab in multiple sclerosis: recurrence of disease activity despite switching to glatiramer acetate
9 auth.
J. Havla,
L. Gerdes,
I. Meinl,
M. Krumbholz,
H. Faber,
F. Weber,
...
H. Pellkofer,
R. Hohlfeld,
T. Kümpfel
|
6 |
2011 |
6 🐜
|
🐜
|
MANBA, CXCR5, SOX8, RPS6KB1 and ZBTB46 are genetic risk loci for multiple sclerosis.
58 auth.
C. Lill,
B. Schjeide,
C. Graetz,
M. Ban,
A. Alcina,
M. A. Ortiz,
Jennifer Pérez,
V. Damotte,
D. Booth,
Aitzkoa Lopez de Lapuente,
L. Broer,
M. Schilling,
D. Akkad,
O. Aktas,
I. Alloza,
...
A. Antigüedad,
R. Arroyo,
P. Blaschke,
M. Buttmann,
A. Chan,
Alastair Compston,
I. Cournu-Rebeix,
T. Dörner,
J. Epplen,
Ó. Fernández,
L. Gerdes,
L. Guillot-nöel,
H. Hartung,
S. Hoffjan,
G. Izquierdo,
A. Kemppinen,
A. Kroner,
C. Kubisch,
T. Kümpfel,
Shu-Chen Li,
U. Lindenberger,
P. Lohse,
C. Lubetzki,
F. Luessi,
S. Malhotra,
J. Mescheriakova,
X. Montalban,
C. Papeix,
L. F. Paredes,
P. Rieckmann,
E. Steinhagen-Thiessen,
A. Winkelmann,
U. Zettl,
R. Hintzen,
K. Vandenbroeck,
G. Stewart,
B. Fontaine,
M. Comabella,
E. Urcelay,
F. Matesanz,
S. Sawcer,
L. Bertram,
F. Zipp
|
6 |
2013 |
6 🐜
|